NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 254 filers reported holding NEOGENOMICS INC in Q3 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,234,956 | -24.9% | 506,907 | -1.9% | 0.02% | -20.0% |
Q2 2023 | $8,302,871 | -10.3% | 516,669 | -2.8% | 0.03% | -18.9% |
Q1 2023 | $9,256,392 | +74.1% | 531,671 | -7.6% | 0.04% | +60.9% |
Q4 2022 | $5,317,352 | +11.8% | 575,471 | +4.2% | 0.02% | +4.5% |
Q3 2022 | $4,757,000 | +101.7% | 552,469 | +90.9% | 0.02% | +120.0% |
Q2 2022 | $2,359,000 | -42.9% | 289,432 | -14.9% | 0.01% | -28.6% |
Q1 2022 | $4,132,000 | -65.9% | 340,080 | -4.3% | 0.01% | -63.2% |
Q4 2021 | $12,120,000 | -30.4% | 355,215 | -1.6% | 0.04% | -35.6% |
Q3 2021 | $17,423,000 | +11.3% | 361,172 | +4.2% | 0.06% | +9.3% |
Q2 2021 | $15,654,000 | -2.8% | 346,556 | +3.8% | 0.05% | -11.5% |
Q1 2021 | $16,103,000 | +3.0% | 333,884 | +14.9% | 0.06% | +7.0% |
Q4 2020 | $15,639,000 | +41.0% | 290,480 | -3.4% | 0.06% | +21.3% |
Q3 2020 | $11,094,000 | +23.7% | 300,742 | +3.9% | 0.05% | +9.3% |
Q2 2020 | $8,965,000 | +16.3% | 289,376 | +3.6% | 0.04% | -10.4% |
Q1 2020 | $7,709,000 | -14.5% | 279,214 | -9.4% | 0.05% | +4.3% |
Q4 2019 | $9,015,000 | +48.0% | 308,215 | -3.2% | 0.05% | +31.4% |
Q3 2019 | $6,091,000 | -16.6% | 318,568 | -4.3% | 0.04% | -16.7% |
Q2 2019 | $7,301,000 | +25.7% | 332,783 | +17.3% | 0.04% | +20.0% |
Q1 2019 | $5,806,000 | +66.6% | 283,751 | +2.7% | 0.04% | +40.0% |
Q4 2018 | $3,485,000 | -24.1% | 276,352 | -7.6% | 0.02% | -10.7% |
Q3 2018 | $4,590,000 | +26.3% | 299,044 | +7.9% | 0.03% | +12.0% |
Q2 2018 | $3,635,000 | +52.0% | 277,259 | -5.4% | 0.02% | +47.1% |
Q1 2018 | $2,391,000 | -20.1% | 292,957 | -13.3% | 0.02% | -15.0% |
Q4 2017 | $2,994,000 | -35.4% | 337,871 | -18.9% | 0.02% | -42.9% |
Q3 2017 | $4,634,000 | +36.9% | 416,390 | +10.3% | 0.04% | +40.0% |
Q2 2017 | $3,384,000 | +21.0% | 377,672 | +8.1% | 0.02% | +8.7% |
Q1 2017 | $2,797,000 | +29.1% | 349,459 | +38.2% | 0.02% | +21.1% |
Q4 2016 | $2,167,000 | +14.2% | 252,820 | +9.5% | 0.02% | +11.8% |
Q3 2016 | $1,898,000 | +40.8% | 230,891 | +37.7% | 0.02% | +30.8% |
Q2 2016 | $1,348,000 | +88.8% | 167,638 | +58.2% | 0.01% | +85.7% |
Q1 2016 | $714,000 | -78.3% | 105,938 | -74.7% | 0.01% | -77.4% |
Q4 2015 | $3,294,000 | +39.1% | 418,604 | +1.3% | 0.03% | +55.0% |
Q3 2015 | $2,368,000 | +1.3% | 413,287 | -4.4% | 0.02% | +566.7% |
Q2 2015 | $2,337,000 | +3058.1% | 432,130 | +2600.8% | 0.00% | – |
Q1 2015 | $74,000 | – | 16,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |